462 related articles for article (PubMed ID: 25855554)
21. Cross-protection of a modified-live porcine reproductive and respiratory syndrome virus (PRRSV)-2 vaccine against a heterologous PRRSV-1 challenge in late-term pregnancy gilts.
Jeong J; Park C; Oh T; Park KH; Yang S; Kang I; Park SJ; Chae C
Vet Microbiol; 2018 Sep; 223():119-125. PubMed ID: 30173737
[TBL] [Abstract][Full Text] [Related]
22. Dendritic cell-targeted porcine reproductive and respiratory syndrome virus (PRRSV) antigens adjuvanted with polyinosinic-polycytidylic acid (poly (I:C)) induced non-protective immune responses against heterologous type 2 PRRSV challenge in pigs.
Subramaniam S; Piñeyro P; Derscheid RJ; Madson DM; Magstadt DR; Meng XJ
Vet Immunol Immunopathol; 2017 Aug; 190():18-25. PubMed ID: 28778318
[TBL] [Abstract][Full Text] [Related]
23. Pigs immunized with Chinese highly pathogenic PRRS virus modified live vaccine are protected from challenge with North American PRRSV strain NADC-20.
Galliher-Beckley A; Li X; Bates JT; Madera R; Waters A; Nietfeld J; Henningson J; He D; Feng W; Chen R; Shi J
Vaccine; 2015 Jul; 33(30):3518-25. PubMed ID: 26049004
[TBL] [Abstract][Full Text] [Related]
24. Enhancing heterologous protection in pigs vaccinated with chimeric porcine reproductive and respiratory syndrome virus containing the full-length sequences of shuffled structural genes of multiple heterologous strains.
Tian D; Cao D; Lynn Heffron C; Yugo DM; Rogers AJ; Overend C; Matzinger SR; Subramaniam S; Opriessnig T; LeRoith T; Meng XJ
Vaccine; 2017 Apr; 35(18):2427-2434. PubMed ID: 28343773
[TBL] [Abstract][Full Text] [Related]
25. Efficacy of an attenuated European subtype 1 porcine reproductive and respiratory syndrome virus (PRRSV) vaccine in pigs upon challenge with the East European subtype 3 PRRSV strain Lena.
Trus I; Bonckaert C; van der Meulen K; Nauwynck HJ
Vaccine; 2014 May; 32(25):2995-3003. PubMed ID: 24709589
[TBL] [Abstract][Full Text] [Related]
26. Efficacy of a modified-live virus vaccine in pigs experimentally infected with a highly pathogenic porcine reproductive and respiratory syndrome virus type 1 (HP-PRRSV-1).
Canelli E; Catella A; Borghetti P; Ferrari L; Ogno G; De Angelis E; Bonilauri P; Guazzetti S; Nardini R; Martelli P
Vet Microbiol; 2018 Nov; 226():89-96. PubMed ID: 30389048
[TBL] [Abstract][Full Text] [Related]
27. Comparative effects of vaccination against porcine circovirus type 2 (PCV2) and porcine reproductive and respiratory syndrome virus (PRRSV) in a PCV2-PRRSV challenge model.
Park C; Oh Y; Seo HW; Han K; Chae C
Clin Vaccine Immunol; 2013 Mar; 20(3):369-76. PubMed ID: 23302743
[TBL] [Abstract][Full Text] [Related]
28. A modified-live porcine reproductive and respiratory syndrome virus (PRRSV)-1 vaccine protects late-term pregnancy gilts against heterologous PRRSV-1 but not PRRSV-2 challenge.
Jeong J; Kang I; Kim S; Park SJ; Park KH; Oh T; Yang S; Chae C
Transbound Emerg Dis; 2018 Oct; 65(5):1227-1234. PubMed ID: 29536637
[TBL] [Abstract][Full Text] [Related]
29. Development of a broadly protective modified-live virus vaccine candidate against porcine reproductive and respiratory syndrome virus.
Sun H; Workman A; Osorio FA; Steffen D; Vu HLX
Vaccine; 2018 Jan; 36(1):66-73. PubMed ID: 29174314
[TBL] [Abstract][Full Text] [Related]
30. Cell-mediated immune response and protective efficacy of porcine reproductive and respiratory syndrome virus modified-live vaccines against co-challenge with PRRSV-1 and PRRSV-2.
Madapong A; Saeng-Chuto K; Boonsoongnern A; Tantituvanont A; Nilubol D
Sci Rep; 2020 Feb; 10(1):1649. PubMed ID: 32015495
[TBL] [Abstract][Full Text] [Related]
31. Enhanced immune responses in pigs by DNA vaccine coexpressing GP3 and GP5 of European type porcine reproductive and respiratory syndrome virus.
Ren J; Lu H; Wen S; Sun W; Yan F; Chen X; Jing J; Liu H; Liu C; Xue F; Xiao P; Xin S; Jin N
J Virol Methods; 2014 Sep; 206():27-37. PubMed ID: 24882496
[TBL] [Abstract][Full Text] [Related]
32. An experimental live chimeric porcine circovirus 1-2a vaccine decreases porcine circovirus 2b viremia when administered intramuscularly or orally in a porcine circovirus 2b and porcine reproductive and respiratory syndrome virus dual-challenge model.
Opriessnig T; Gomes-Neto JC; Hemann M; Shen HG; Beach NM; Huang Y; Halbur PG; Meng XJ
Microbiol Immunol; 2011 Dec; 55(12):863-73. PubMed ID: 21951266
[TBL] [Abstract][Full Text] [Related]
33. Comparison of 4 commercial modified-live porcine reproductive and respiratory syndrome virus (PRRSV) vaccines against heterologous Korean PRRSV-1 and PRRSV-2 challenge.
Oh T; Kim H; Park KH; Yang S; Jeong J; Kim S; Kang I; Park SJ; Chae C
Can J Vet Res; 2019 Jan; 83(1):57-67. PubMed ID: 30670903
[TBL] [Abstract][Full Text] [Related]
34. A comparison of commercial modified-live PRRSV-1 and PRRSV-2 vaccines against a dual heterologous PRRSV-1 and PRRSV-2 challenge in late term pregnancy gilts.
Yang S; Oh T; Cho H; Chae C
Comp Immunol Microbiol Infect Dis; 2020 Apr; 69():101423. PubMed ID: 31972500
[TBL] [Abstract][Full Text] [Related]
35. Comparison of protection provided by type 1 and type 2 porcine reproductive and respiratory syndrome field viruses against homologous and heterologous challenge.
Choi K; Park C; Jeong J; Chae C
Vet Microbiol; 2016 Aug; 191():72-81. PubMed ID: 27374910
[TBL] [Abstract][Full Text] [Related]
36. Intranasal immunization of pigs with porcine reproductive and respiratory syndrome virus-like particles plus 2', 3'-cGAMP VacciGrade™ adjuvant exacerbates viremia after virus challenge.
Van Noort A; Nelsen A; Pillatzki AE; Diel DG; Li F; Nelson E; Wang X
Virol J; 2017 Apr; 14(1):76. PubMed ID: 28403874
[TBL] [Abstract][Full Text] [Related]
37. Immune responses of pigs inoculated with a recombinant fowlpox virus coexpressing GP5/GP3 of porcine reproductive and respiratory syndrome virus and swine IL-18.
Shen G; Jin N; Ma M; Jin K; Zheng M; Zhuang T; Lu H; Zhu G; Jin H; Jin M; Huo X; Qin X; Yin R; Li C; Li H; Li Y; Han Z; Chen Y; Jin M
Vaccine; 2007 May; 25(21):4193-202. PubMed ID: 17418456
[TBL] [Abstract][Full Text] [Related]
38. Assessment of the safety and efficacy of an attenuated live vaccine based on highly pathogenic porcine reproductive and respiratory syndrome virus.
Yu X; Zhou Z; Cao Z; Wu J; Zhang Z; Xu B; Wang C; Hu D; Deng X; Han W; Gu X; Zhang S; Li X; Wang B; Zhai X; Tian K
Clin Vaccine Immunol; 2015 May; 22(5):493-502. PubMed ID: 25739919
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of a 20year old porcine reproductive and respiratory syndrome (PRRS) modified live vaccine (Ingelvac(®) PRRS MLV) against two recent type 2 PRRS virus isolates in South Korea.
Jeong J; Choi K; Kang I; Park C; Chae C
Vet Microbiol; 2016 Aug; 192():102-109. PubMed ID: 27527771
[TBL] [Abstract][Full Text] [Related]
40. Positive inductive effect of swine interleukin-4 on immune responses elicited by modified live porcine reproductive and respiratory syndrome virus (PRRSV) vaccine.
Peng J; Wang J; Wu J; Du Y; Li J; Guo Z; Yu J; Xu S; Zhang Y; Sun W; Cong X; Shi J
Viral Immunol; 2013 Dec; 26(6):404-14. PubMed ID: 24328935
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
